US · Healthcare
Biotechnology
AC Immune Ltd (ACIU) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
The price-to-earnings (P/E) ratio for AC Immune Ltd (ACIU) is 25.00 (data as of 2026-05-23).
Dividend yield is not available in the current snapshot for AC Immune Ltd (ACIU). Check the MyAverix Finance app for the latest dividend data.
AC Immune Ltd (ACIU) is classified in the Healthcare sector (Biotechnology industry).
ACIU is listed on US.
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.